Apr 6, 2020 11:29 PM
BACK TO TOP
KSE100
30,579.15
-1042.64
(-3.30%)
ALLSHR
22,022.22
-493.37
(-2.19%)
KSE30
13,526.01
-488.74
(-3.49%)
KMI30
48,022.16
-1700.37
(-3.42%)
BKTi
10,469.41
-386.11
(-3.56%)
OGTi
11,191.63
-48.50
(-0.43%)
KMIALLSHR
14,589.99
-415.01
(-2.77%)
UPP9
9,471.92
-397.42
(-4.03%)
NITPGI
7,134.15
-218.18
(-2.97%)
GlaxoSmithKline Consumer Healthcare
PHARMACEUTICALS
Rs.196.29
-8.20
(-4.01%)
1D
1M
6M
YTD
1Y
3Y
5Y
As of Mon, Apr 6, 2020 3:41 PM
REG
FUT
ODL
Open
204.44
High
204.50
Low
196.00
Volume
16,400
CIRCUIT BREAKER
189.15 — 219.83
DAY RANGE
196.00 — 204.50
52-WEEK RANGE
161.00 — 314.99
Ask Price
196.29
Ask Volume
300
Bid Price
0.00
Bid Volume
0
LDCP
204.49
VAR
14.85
HAIRCUT
19.25
P/E Ratio (TTM)
18.28
1-Year Change *
-37.68%
YTD Change *
-23.45%
Open
204.00
High
217.90
Low
200.00
Close
217.47
Change
6.35%
LDCP
204.49
Volume
33
Total Trades
7
CIRCUIT BREAKER
184.04 — 224.94
DAY RANGE
200.00 — 217.90
Ask Price
217.23
Ask Volume
8
Bid Price
195.10
Bid Volume
2
Market data powered by capitalstake.com. Provided by PSX.* Returns not adjusted for payouts

Company Profile

BUSINESS DESCRIPTION

GlaxoSmithKline Consumer Healthcare Pakistan Limited was incorporated in Pakistan as a public unlisted company under the provisions of the repealed Companies Ordinance, 1984 (now Companies Act, 2017). The Company is a subsidiary of GlaxoSmithKline Consumer Healthcare B.V. The ultimate parent of the Company is GlaxoSmithKline plc, UK. The Company is engaged in manufacturing, marketing and sale of consumer healthcare products.

KEY PEOPLE
Mr. M.Z. Moin MohajirChairman
Mr. Sohail MatinCEO
Ms. Mehar-e-Daraksha AmeerCompany Secretary
ADDRESS

35 – Dockyard Road, West Wharf, Karachi – 74000

WEBSITE

www.pk-consumerhealthcare.gsk.com

REGISTRAR

CDC Share Registrar Services Limited

AUDITOR

Deloitte Yousuf Adil Chartered Accountants

Fiscal Year End

December

Equity Profile

Market Cap (000's)
22,976,629.38
Shares
117,054,508
Free Float
15,494,804
Free Float
13.24%

Announcements

Financial Results
Board Meetings
Others
DateTitleDocument
Oct 30, 2019Transmission of Quarterly Report for the Period Ended 2019-09-30 View   PDF
Oct 25, 2019Financial Results for the Quarter Ended 30 September 2019 View   PDF
Aug 29, 2019Transmission of Quarterly Report for the Period Ended June 30, 2019 View   PDF
Aug 27, 2019Financial Results for the Half Year Ended 2019-06-30 View   PDF
Apr 30, 2019Transmission of Quarterly Report for the Period Ended 31 March 2019 View   PDF
Apr 24, 2019Financial Results for the Quarter Ended 31 March 2019 View   PDF
Apr 2, 2019Transmission of Annual Report for the Year Ended 31 December 2018 View   PDF
Oct 30, 2018Transmission of Quarterly Report for the Period Ended 30 September 2018 View   PDF
Oct 30, 2018Financial Results for the Quarter Ended 30 September 2018 View   PDF
Aug 30, 2018 Transmission of Quarterly Report for the Period Ended June 30, 2018 View   PDF
DateTitleDocument
Mar 25, 2020GSKCH | GlaxoSmithKline Consumer Healthcare Pakistan Limited - Postponement of Annual General Meeting PDF
Mar 6, 2020Board Meeting View   PDF
Mar 5, 2020Board Meeting View   PDF
Oct 18, 2019Board Meeting View   PDF
Aug 20, 2019Board of Directors Meeting View   PDF
Jun 21, 2019Board Meeting Other than Financial Results View   PDF
Jun 14, 2019Board Meeting Other than Financial Results View   PDF
Apr 23, 2019Meeting in Progress - Q1-2019 - Board Meeting - 23 April 2019 View   PDF
Apr 2, 2019Notice of Annual General Meeting 2019-04-23 View   PDF
Mar 11, 2019Board Meeting - Q4-2018 View   PDF
DateTitleDocument
Mar 20, 2020Miscellaneous Information View   PDF
Mar 17, 2020Miscellaneous Information View   PDF
Mar 17, 2020Material Information View   PDF
Mar 16, 2020Material Information View   PDF
Mar 13, 2020Material Information View   PDF
Mar 12, 2020GSKCH | GlaxoSmithKline Consumer Healthcare Pakistan Limited PDF
Jan 17, 2020Material Information View   PDF
Dec 20, 2019Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View   PDF
Oct 1, 2019Corporate Briefing Session - GSK CHC Pakistan Limited View   PDF
Aug 27, 2019Change of Company Secretary View   PDF

Financials

All numbers in thousands (000's) except EPS

Annual
Quarterly
2019201820172016
Sales16,316,74514,875,2688,298,1425,375,805
Profit after Taxation1,257,5191,074,553706,815545,467
EPS10.749.187.397.60
Q3 2019Q2 2019Q1 2019
Sales3,913,6574,025,7323,872,871
Profit after Taxation279,525441,503167,315
EPS2.393.771.43
Data powered by Capital Stake. To provide comparable data, information might have been standardized. The data presented may therefore differ from issuer's annual report and 'as reported' data should be obtained directly from the source issuer. See the Capital Stake Terms of Use.

Ratios

2019201820172016
Gross Profit Margin (%)30.5629.1837.3728.07
Net Profit Margin (%)7.717.228.5210.15
EPS Growth (%)16.9924.22(2.76)
PEG1.401.20(15.75)

Payouts

DateFinancial ResultsDetailsBook Closure
March 12, 2020 6:23 PM31/12/2019(YR) 50%(F) (D) 16/04/2020 - 22/04/2020
March 18, 2019 5:17 PM31/12/2018(YR) 50%(F) (D) 18/04/2019 - 23/04/2019
January 29, 2018 3:23 PM31/12/2017(YR) 50% (D) 23/03/2018 - 29/03/2018

Financial Reports